[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2012 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- -33.55%
YoY- 18.32%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 1,838,372 1,875,944 2,001,356 1,812,346 1,773,256 1,806,964 1,786,980 1.90%
PBT 79,986 93,058 147,696 103,313 132,088 141,146 171,820 -39.90%
Tax -32,661 -30,410 -47,084 -40,108 -37,856 -50,870 -55,576 -29.81%
NP 47,325 62,648 100,612 63,205 94,232 90,276 116,244 -45.03%
-
NP to SH 45,849 61,272 99,084 61,710 92,860 88,796 114,740 -45.71%
-
Tax Rate 40.83% 32.68% 31.88% 38.82% 28.66% 36.04% 32.35% -
Total Cost 1,791,046 1,813,296 1,900,744 1,749,141 1,679,024 1,716,688 1,670,736 4.74%
-
Net Worth 473,857 481,681 484,829 471,886 496,623 481,282 474,161 -0.04%
Dividend
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Div 33,903 35,323 35,303 41,187 39,227 35,301 35,297 -2.64%
Div Payout % 73.95% 57.65% 35.63% 66.74% 42.24% 39.76% 30.76% -
Equity
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Net Worth 473,857 481,681 484,829 471,886 496,623 481,282 474,161 -0.04%
NOSH 258,938 258,968 117,676 117,677 117,683 117,672 117,657 69.11%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 2.57% 3.34% 5.03% 3.49% 5.31% 5.00% 6.51% -
ROE 9.68% 12.72% 20.44% 13.08% 18.70% 18.45% 24.20% -
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 709.97 724.39 1,700.72 1,540.10 1,506.80 1,535.58 1,518.79 -39.74%
EPS 17.71 23.66 84.20 52.44 78.91 75.46 97.52 -67.89%
DPS 13.09 13.64 30.00 35.00 33.33 30.00 30.00 -42.44%
NAPS 1.83 1.86 4.12 4.01 4.22 4.09 4.03 -40.89%
Adjusted Per Share Value based on latest NOSH - 117,715
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 127.56 130.16 138.86 125.75 123.04 125.38 123.99 1.90%
EPS 3.18 4.25 6.87 4.28 6.44 6.16 7.96 -45.72%
DPS 2.35 2.45 2.45 2.86 2.72 2.45 2.45 -2.73%
NAPS 0.3288 0.3342 0.3364 0.3274 0.3446 0.3339 0.329 -0.04%
Price Multiplier on Financial Quarter End Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 -
Price 4.82 4.49 8.26 8.10 7.55 10.18 5.90 -
P/RPS 0.68 0.62 0.49 0.53 0.50 0.66 0.39 44.81%
P/EPS 27.22 18.98 9.81 15.45 9.57 13.49 6.05 172.28%
EY 3.67 5.27 10.19 6.47 10.45 7.41 16.53 -63.30%
DY 2.72 3.04 3.63 4.32 4.42 2.95 5.08 -34.03%
P/NAPS 2.63 2.41 2.00 2.02 1.79 2.49 1.46 47.99%
Price Multiplier on Announcement Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 -
Price 4.72 4.66 9.26 7.80 8.25 8.83 5.90 -
P/RPS 0.66 0.64 0.54 0.51 0.55 0.58 0.39 41.96%
P/EPS 26.66 19.70 11.00 14.87 10.46 11.70 6.05 168.54%
EY 3.75 5.08 9.09 6.72 9.56 8.55 16.53 -62.76%
DY 2.77 2.93 3.24 4.49 4.04 3.40 5.08 -33.23%
P/NAPS 2.58 2.51 2.25 1.95 1.95 2.16 1.46 46.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment